Kaszubiak A - Search Results

1

Population structure and evolutionary origins of Microsporum canis, M. ferrugineum and M. audouinii.

Kaszubiak A, Klein S, de Hoog GS, Gräser Y. Kaszubiak A, et al. Infect Genet Evol. 2004 Sep;4(3):179-86. doi: 10.1016/j.meegid.2003.12.004. Infect Genet Evol. 2004. PMID: 15450196

2

Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.

Kaszubiak A, Holm PS, Lage H. Kaszubiak A, et al. Int J Oncol. 2007 Aug;31(2):419-30. Int J Oncol. 2007. PMID: 17611700

3

Complete in vivo reversal of the multidrug resistance phenotype by jet-injection of anti-MDR1 short hairpin RNA-encoding plasmid DNA.

Stein U, Walther W, Stege A, Kaszubiak A, Fichtner I, Lage H. Stein U, et al. Among authors: kaszubiak a. Mol Ther. 2008 Jan;16(1):178-86. doi: 10.1038/sj.mt.6300304. Epub 2007 Sep 18. Mol Ther. 2008. PMID: 17878902 Free article.

4

Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents.

Mantwill K, Köhler-Vargas N, Bernshausen A, Bieler A, Lage H, Kaszubiak A, Surowiak P, Dravits T, Treiber U, Hartung R, Gansbacher B, Holm PS. Mantwill K, et al. Among authors: kaszubiak a. Cancer Res. 2006 Jul 15;66(14):7195-202. doi: 10.1158/0008-5472.CAN-05-2339. Cancer Res. 2006. PMID: 16849566

5

Impact of radiation therapy on the oncolytic adenovirus dl520: implications on the treatment of glioblastoma.

Bieler A, Mantwill K, Holzmüller R, Jürchott K, Kaszubiak A, Stärk S, Glockzin G, Lage H, Grosu AL, Gansbacher B, Holm PS. Bieler A, et al. Among authors: kaszubiak a. Radiother Oncol. 2008 Mar;86(3):419-27. doi: 10.1016/j.radonc.2007.10.009. Epub 2007 Oct 29. Radiother Oncol. 2008. PMID: 17967494

6

Adenovirus-based virotherapy enabled by cellular YB-1 expression in vitro and in vivo.

Rognoni E, Widmaier M, Haczek C, Mantwill K, Holzmüller R, Gansbacher B, Kolk A, Schuster T, Schmid RM, Saur D, Kaszubiak A, Lage H, Holm PS. Rognoni E, et al. Among authors: kaszubiak a. Cancer Gene Ther. 2009 Oct;16(10):753-63. doi: 10.1038/cgt.2009.20. Epub 2009 Apr 10. Cancer Gene Ther. 2009. PMID: 19363467

7

Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer.

Noske A, Kaszubiak A, Weichert W, Sers C, Niesporek S, Koch I, Schaefer B, Sehouli J, Dietel M, Lage H, Denkert C. Noske A, et al. Among authors: kaszubiak a. Cancer Lett. 2007 Feb 8;246(1-2):190-200. doi: 10.1016/j.canlet.2006.02.018. Epub 2006 Apr 3. Cancer Lett. 2007. PMID: 16584837

8

Regulation of MDR1 gene expression in multidrug-resistant cancer cells is independent from YB-1.

Kaszubiak A, Kupstat A, Müller U, Hausmann R, Holm PS, Lage H. Kaszubiak A, et al. Biochem Biophys Res Commun. 2007 May 25;357(1):295-301. doi: 10.1016/j.bbrc.2007.03.145. Epub 2007 Apr 2. Biochem Biophys Res Commun. 2007. PMID: 17418094

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page